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The targeting and assembly of nuclear-encoded mitochondrial proteins are essential processes because the energy supply of humans is
dependent upon the proper functioning of mitochondria. Defective import of mitochondrial proteins can arise from mutations in the targeting
signals within precursor proteins, from mutations that disrupt the proper functioning of the import machinery, or from deficiencies in the
chaperones involved in the proper folding and assembly of proteins once they are imported. Defects in these steps of import have been shown to
lead to oxidative stress, neurodegenerative diseases, and metabolic disorders. In addition, protein import into mitochondria has been found to be a
dynamically regulated process that varies in response to conditions such as oxidative stress, aging, drug treatment, and exercise. This review
focuses on how mitochondrial protein import affects human health and disease.
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Proteins act as hormones, receptors, enzymes, channels, and
structural components within the cell, and although most are
synthesized by the same set of cytosolic ribosomes, each protein
has a specific subcellular location in which it resides and
functions properly. Blobel and colleagues first postulated the
“signal hypothesis”, which predicted that proteins contain “zip
codes” within their amino acid sequences that determine their
subcellular location [1,2]. The importance of this hypothesis
was supported by the finding that preproinsulin from two
different fish species could be efficiently imported into dog
pancreas microsomal vesicles, confirming that the system of
protein targeting is evolutionarily conserved throughout nature
[3]. In addition to specific targeting and compartmentalization
within the cell, proteins also undergo post-translational
modifications such as processing, folding, and oligomerization.
Errors in any of the steps that proteins must go through before
they become fully active in their proper location can result in
disease. While a great deal of attention has been focused on how⁎ Corresponding author. Tel.: +1 315 312 3031; fax: +1 315 312 3059.
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(e.g., cystic fibrosis, hypercholesterolemia, Alzheimer's) [4],
there has been little focus on how problems in mitochondrial
protein import contribute to human health and disease. This
review addresses how errors in the molecular mechanisms of
import can lead to human disease, and also how mitochondrial
protein import is variable and can be altered by various
conditions. In order to appreciate the complexity of mitochon-
drial protein import and how it relates to disease, we begin with a
brief overview of the import mechanisms.
2. Mitochondrial protein import
The targeting and import of mitochondrial proteins involve a
series of receptors, import pores, and molecular machines
located in the four intra-mitochondrial locations; the outer and
inner mitochondrial membranes, the intermembrane space
(IMS), and the matrix [5,6]. Most mitochondrial proteins are
synthesized by free cytosolic ribosomes and are imported post-
translationally (Fig. 1). All nuclearly-encoded mitochondrial
proteins initially enter mitochondria via the protein translocase
machinery of the outer membrane (TOM complex). From there,
they are sorted to their final destination by the combined actions
Fig. 1. Mitochondrial protein import pathways. Most mitochondrial proteins are
predicted to be synthesized in their entirety in the cytosol and are then imported
post-translationally. Proteins are maintained in an import-competent state by
cytosolic chaperones and are specifically targeted to receptors at the
mitochondrial surface. Proteins are then transferred from the receptors to the
general import pore of the outer membrane, the TOM complex. Once across the
outer membrane, proteins are sorted to one of the four intra-mitochondrial
locations. Outer membrane proteins are inserted into the membrane either by the
TOM or the sorting and assembly machinery (SAM) complex. Matrix proteins
are sorted via the TIM23 complex and the presequence translocase-associated
motor (PAM), while some single-pass inner membrane proteins are directly
inserted into the membrane. Once matrix proteins cross the inner membrane,
they are processed and folded via mitochondrial processing peptidase (MPP)
and matrix chaperonins, respectively. Some single-pass inner membrane
proteins are re-exported via OXA after being imported into the matrix.
Polytopic inner membrane proteins are guided across the intermembrane space
by the small Tim proteins (Tim9/10, Tim8/13) to the TIM22 complex where they
are inserted into the inner membrane. The red stars denote import factors that
either cause a disease state, or represent acquired changes.
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encoded within the protein.
2.1. Targeting signals and cytosolic chaperones
Precursor proteins possessing a cleavable amino-terminal
targeting signal (N-MTS) are destined for the IMS, the inner
membrane, or the matrix. An N-MTS usually consists of about
20–30 amino acids, and although there is no sequence identity
shared between N-MTSs, they all form amphiphilic α-helices
that are enriched in basic, hydroxylated, and hydrophobic
residues [7–9]. The helicity of N-MTS can also be interrupted
by a central flexible linker region [10,11]. The physical
interactions that occur between the N-MTS and the transloca-
tion machinery are not well understood, but data indicate that
the basic and hydrophobic residues of the N-MTS are vital
[12–14]. According to the ‘acid-chain’ hypothesis, the basic
amino acids interact electrostatically with domains of the
translocation machinery that have a high content of acidicamino acids [15,16]. The basic residues are not essential for
import because their loss can be compensated for by the
removal of the linker region, which results in increased helical
stability and length [17–19]. The linker region and hydro-
phobic residues are believed to be important for early
recognition by receptor components, whereas the basic residues
are utilized in subsequent import steps [12–14].
Outer and inner membrane proteins contain internal targeting
sequences that are not cleaved after import, and in contrast to N-
MTSs, they are not well characterized. Outer membrane
proteins either possess an anchoring sequence at the amino-
or carboxy-terminus (single pass proteins), or have their
targeting information encoded in structural elements that
involve different regions of the protein (β-barrel proteins)
[20]. Most of our knowledge of polytopic inner membrane
protein targeting signals comes from studies of the ATP/ADP
carrier protein (AAC). AAC belongs to a family of carrier
proteins that have three distinct regions that are involved in
import, each consisting of a pair of transmembrane domains
(TMDs) connected by a matrix-exposed loop [21,22].
Newly synthesized proteins interact with cytoplasmic
chaperones, which prevent their aggregation and keep them
unfolded so they may be translocated through the import pores
[23]. Which TOM receptor recognizes the chaperone–precursor
protein complex depends upon the chaperone and the nature of
the targeting sequence [24,25]. Hsc70 transfers precursor
proteins to the Tom20/22 receptor complex, which preferen-
tially binds to proteins containing an N-MTS [13,14,25,26].
Mammals contain additional cytosolic factors that act as co-
chaperones with Hsc70. Arylhydrocarbon receptor interacting
protein (AIP) binds to Hsc70, the N-MTS, and Tom20, and
prevents substrate aggregation and enhances import [27]. The
type I DnaJ homologs DjA1 and DjA2 enhance both the ATPase
activity of Hsc70 and protein import [28,29]. Mammalian
Hsp90, in conjunction with Hsc70, delivers proteins to Tom70
[30], which binds internal targeting sequences [24,31]. Proteins
delivered to Tom70 are first passed to Tom20/22 [32,33], which
then transfers proteins to the general import pore (GIP) [34].
2.2. Translocation across, or insertion into, the outer
membrane
The GIP forms the central unit of the TOM and in yeast
contains Tom40, Tom22, and the small Tom proteins (Tom5,
Tom6, and Tom7) [34–36]. Mammals contain a similar
complex [37–40], although Tom5 and Tom6 have yet to be
identified. Tom40 forms the channel across the membrane and
contains N-MTS binding sites that are spatially arranged from
the cis to the trans side of the pore [16,41–43]. The
translocation of proteins with internal targeting sequences is
not well understood, but it appears as though the protein spans
Tom40 as a hairpin-like structure that exposes the loop
connecting two TMDs to the IMS [21]. After translocation
across the outer membrane, the sorting pathways diverge to
either one of the translocase of the inner membrane complexes
(TIM23 or TIM22), or to the sorting and assembly machinery
(SAM) complex.
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are released directly into the membrane from the TOM
complex; however, the mechanism for such a transfer is still
unclear [44]. Outer membrane β-barrel proteins are inserted into
the membrane via the SAM complex after they have been
translocated across the outer membrane [45–47]. The yeast
SAM complex is comprised of Sam50, Sam35, Sam37, and
Mdm10 [48], and its importance is demonstrated by Sam50
being essential for yeast viability [46]. Very little is known
about the role of the SAM complex in mammals and only
Sam50 has been identified [49,50].
2.3. Translocation across the inner membrane and processing
in the matrix
The TIM23 complex sorts precursor proteins with an N-MTS
and consists of Tim17, Tim21, Tim23, and Tim50 [51]. Tim23
forms the channel across the inner membrane, and translocation
across the membrane requires the inner membrane electro-
chemical potential (ΔΨ) and the presence of an N-MTS
[52,53]. Precursor protein transfer from the TOM complex to
TIM23 involves the interaction of the IMS domain of Tom22
with Tim23 and Tim50 [54–57]. Tim50 also promotes the
closure of the Tim23 channel in the absence of precursor
proteins, allowing for a tight regulation of the ΔΨ [58]. Tim17
and Tim21 are involved in switching between a TIM23 complex
that inserts proteins into the inner membrane and one that
imports proteins into the matrix by either promoting TOM
tethering or recruiting the presequence translocase-associated
motor (PAM), respectively [59].
Once the N-MTS of matrix-bound proteins crosses the
inner membrane, it interacts with the PAM, which is a
dynamic complex of Tim44, Pam16, Pam17, Pam18, Mge1,
Mdj2, and mtHsp70 that uses ATP to “pull” proteins across
the inner membrane [60]. MtHsp70 drives protein transloca-
tion by interacting with the other PAM proteins and cycling
between an ATP- and ADP-bound state, which alters the
affinity of mtHsp70 for the precursor protein [61]. The
required cycling of the ATP/ADP-bound states is regulated by
the nucleotide exchange factor Mge1 [62]. Tim44 tethers
mtHsp70 to the inner membrane by interacting with the
ATPase and peptide-binding domains of mtHsp70, and the
mtHsp70/Tim44 complex is disrupted upon precursor protein
binding through conformational changes in mtHsp70 [63,64].
Pam16, Pam17, Pam18, and Mdj2 are involved in promoting
mtHsp70/Tim44 complex formation, the association of that
complex with TIM23, and the stimulation of mtHsp70 ATPase
activity [65–70].
Once in the matrix, the N-MTS of most precursor proteins is
removed by the mitochondrial processing peptidase (MPP) to
form the mature protein [71]. MPP is a metalloendoprotease that
processes precursor proteins as they are being folded and is only
active in its heterodimeric form consisting of α-MPP and
β-MPP [72–74]. Acidic residues of β-MPP determine the
cleavage site through interaction with the Arg at the −2 position
relative to the cleavage site [75,76]. Other precursor proteins are
processed into their mature form via the sequential cleavagesteps of MPP followed by the mitochondrial intermediate
peptidase [77].
Matrix proteins are folded and assembled into complexes by
the heat shock proteins mtHsp70, Hsp60, and Hsp10 [78].
MtHsp70 functions in one of two complexes; as part of the
aforementioned PAM complex, and as part of a protein folding
complex [79]. The mtHsp70 folding complex utilizes the co-
chaperones Mge1 and Mdj1, which enhance the ATPase activity
of mtHsp70, and hence its ATP/ADP cycling and protein
folding functions [80,81]. Unlike Mge1, Mdj1 is not involved in
the translocation of proteins across the inner membrane, but
rather, it assists mtHsp70 in protein folding by enabling
mtHsp70 to bind proteins in an ATP-dependent manner [80–
83]. The Hsp60/Hsp10 folding complex uses ATP to fold
proteins and prevent their aggregation [84–87]; however, little
is known about the mechanism of action. Most of our
knowledge is inferred from their bacterial homologs, the
chaperonin GroEL and its co-chaperonin GroES [78,88].
GroEL and Hsp60 both consist of two heptameric toroidal
rings [89,90]. Based on the GroEL/GroES system, Hsp10
coordinates the Hsp60 monomers and regulates the ATPase
activity, and Hsp60 passively provides an environment that
prevents aggregation, thus allowing folding to proceed [91,92].
Indeed, the two-ring structure of mammalian Hsp60 is
promoted in the presence of Hsp10 and ATP [89]. New
evidence however, suggests that the GroEL central cavity might
actively participate in folding by altering folding rate, and for
some proteins, even altering the folding mechanism [93].
2.4. Sorting to the intermembrane space
The localization of proteins with an N-MTS to the IMS is
illustrated by the import of cytochrome b1 and cytochrome b2
[94,95]. These proteins are targeted to the TIM23 complex as
noted above, but become arrested in the pore by an uncharged
“sorting signal” that immediately follows the N-MTS (“stop-
transfer” mechanism). Insertion of the N-MTS into the pore is
driven by the ΔΨ and import does not require mtHsp70 [96].
The N-MTS is cleaved off by MPP in the matrix and the mature
protein is released into the IMS by proteolytic cleavage at the
outer face of the inner membrane by the inner membrane
peptidases [71,97]. IMS proteins containing internal targeting
signals and zinc-finger motifs are translocated across the outer
membrane and retained in the IMS either by binding to metal
cofactors [98–101], or by forming disulfide bonds [102–106].
2.5. Insertion into the inner membrane
Single-pass inner membrane proteins contain an N-MTS and
are inserted into the membrane by one of two mechanisms
[107]. Some proteins have a hydrophobic “stop-transfer” signal
that arrests the protein in the TIM23 complex, followed by the
lateral release of the protein directly into the membrane
[108,109]. Other precursor proteins are imported entirely into
the matrix following the same steps and requirements as matrix
proteins and are then exported from the matrix into the inner
membrane [110–112]. The export process involves the inner
Table 2
Acquired defects in mitochondrial protein import
Condition Effect References
Aging Reduction in the import of mitochondrial




Increased rate of import and increase
in protein import machineries
[195,196]
Oxidative stress Inhibits the import of precursor proteins and




Increased rate of import and increases
in protein import machineries
[191–193]
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the insertion of mitochondrially-encoded proteins into the inner
membrane [115,116].
Polytopic inner membrane proteins are guided through the
IMS by the small TIM proteins Tim8, Tim9, Tim10, Tim12, and
Tim13 [117,118]. Two soluble 70-kDa complexes (Tim9/10 and
Tim8/13) mediate the transfer of integral membrane proteins to
the TIM22 complex [119]. Most polytopic inner membrane
proteins are passed from Tom40 to Tim9/10, which then
complexes with Tim12 to finally transfer the protein to TIM22
[98,120–123]. Other proteins cross the IMS with the help of
Tim8/13 [124]. Protein insertion at the twin-pore TIM22
complex is coordinated by the ΔΨ and the internal targeting
sequence [117,125].
3. Diseases due to variation in mitochondrial targeting
signals
It is clear that the targeting, import, and assembly of
mitochondrial proteins involve a complex series of events
which are dependent on the mitochondrial translocation
machinery and the information encoded in the imported protein.
As we discuss below, errors in these events can result in a
protein not reaching its final destination, ultimately leading to a
disease state in humans (Table 1). In addition to errors in the
import process, mitochondrial protein import is a dynamic
process that can be altered in response to various conditions
(Table 2). Understanding the orchestration of how nuclearly-
encoded proteins reach their final destination in mitochondria is
essential to the understanding of mitochondrial function as a
whole.
3.1. Pyruvate dehydrogenase deficiency
The first report of a defect in a mitochondrial targeting signal
causing a human disease described a mutation in the N-MTS of
one of the subunits of the mitochondrial matrix protein complex
pyruvate dehydrogenase (PDH), that leads to PDH deficiency
[126]. The PDH complex catalyzes the oxidative decarboxyla-
tion of pyruvate to acetyl CoA, and PDH deficiency is one of
the most common causes of primary lactic acidosis in infants
and children [127]. The most common cause of PDH deficiencyTable 1
Abnormal mitochondrial protein import and human health and disease
Disease Protein References
Defects in mitochondria targeting signals
Primary hyperoxaluria type 1 AGT [131,132]
Pyruvate dehydrogenase deficiency PDH E1α [126,128]
Susceptibility to severe alcoholic liver disease MnSOD [147,148]
Defects in the translocation or processing machinery
Atypical mitochondria disease involving
multisystem failure
Hsp60 [173,174]
Dilated cardiomyopathy with ataxia DNAJC19 [172]
Human Deafness Dystonia Syndrome DDP1/Tim 8 [155,156,
158–164]
Spastic Paraplegia-13 Hsp60 [177,178]is a defect in the X-linked PDH E1α subunit, which leads to
significant structural abnormalities of the central nervous
system, including microcephaly and cerebral atrophy [128].
The human E1α protein is synthesized in the cytosol with a 29-
residue N-MTS that is removed in the matrix after import [129].
In two male siblings with X-linked PDH E1α deficiency, a base
substitution of G to C at nucleotide 134 in the gene encoding
PDH E1α was identified that resulted in an Arg→Pro
substitution at codon 10 in the N-MTS [126]. Cultured skin
fibroblasts from these patients had 28% PDH and 23% PDH E1
activity, and showed a decreased PDH E1α protein level.
Mitochondria import assays using chimeric constructs with the
normal and mutant PDH E1α N-MTS indicated that the
mutation caused a decrease in import efficiency. It is unknown
why the R10P mutation decreases import, but the simultaneous
loss of a basic residue and the addition of a potential helix-
breaking residue may seriously affect the functioning of the N-
MTS. The hydrophobic moment of the N-MTS is significantly
reduced in the R10P mutant due to the decrease in the number of
basic residues on the hydrophilic face of the helix [126]. Also,
the addition of the helix-breaking proline could destabilize the
helix, which is important for aligning the basic and hydrophobic
residues in the N-MTS for recognition by the import machinery
[7,8].
3.2. Primary hyperoxaluria type 1
Alanine/glyoxylate aminotransferase 1 (AGT) deficiency
can be caused by its mistargeting to mitochondria leading to
primary hyperoxaluria type 1 (PH1) [130]. AGT catalyzes the
conversion of glyoxylate to glycine in the peroxisomes of
hepatocytes. Although most cases of PH1 are characterized by a
lack of active AGT, approximately one third of patients have
been described in whom AGT is present and active, but is
mistargeted to mitochondria rather than peroxisomes [131,132].
These PH1 patients have at least one allele carrying two
separate point mutations, each of which causes a single amino
acid substitution (P11L and G170R) [132]. The P11L
polymorphism produces a weak mitochondrial targeting
sequence, that in conjunction with the G170R mutation, leads
to the mistargeting of AGT to mitochondria [133,134]. The
G170R mutation, or other mutations also associated with PH1,
must accompany the P11L mutation for the disease phenotype
to occur because they hinder the folding and dimerization of
AGT [135,136]. Unlike protein import into peroxisomes, which
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can only import proteins that are unfolded or loosely folded
monomers [138,139]. Thus, the combination of a weak
targeting signal and the unfolded state of AGT is sufficient
for AGT to be mistargeted to mitochondria. The mistargeting of
AGT disrupts peroxisomal function, leading to glyoxylate being
oxidized to oxalate and the deposition of calcium oxalate in the
kidney and urinary tract, eventually leading to kidney failure
and the deposition of calcium oxalate in almost every organ and
tissue in the body [140].
3.3. Severe alcoholic liver disease
Even if proteins are correctly targeted to mitochondria, they
must also be properly imported and sorted to one of the four
intra-mitochondrial locations. Manganese superoxide dismutase
(MnSOD) is a nuclearly-encoded matrix protein that is targeted
via a cleavable N-MTS [141]. Superoxide anions generated as a
result of oxidative phosphorylation are converted to hydrogen
peroxide by MnSOD, which can then be reduced to water by
glutathione peroxidase (GPX) [142]. A genetic dimorphism for
either Val or Ala at residue 16 exists in the N-MTS of MnSOD
[143,144]. In vitro import studies indicate that while Val-type
precursor proteins are properly targeted to mitochondria, they
become partly arrested in the inner membrane [145]. As
discussed below, this difference in import efficiency can lead to
varying amounts of the enzyme and has been associated with
numerous diseases. The Ala-precursor protein generates 30–
40% more active, processed MnSOD homotetramer than the
Val-precursor protein [145]. Additionally, expression and
activity of the Ala-MnSOD variant is 4x greater than Val-
MnSOD in transfected cells [146]. The translocation difficulty
of Val-MnSOD has been proposed to be caused by a disruption
of the α-helical configuration of the MTS by the presence of Val
[144].
The presence of at least one Ala allele at the MnSOD locus
is a risk factor for severe alcoholic liver disease (microvascular
steatosis, alcoholic hepatitis, and cirrhosis), and increases the
rates of hepatocellular carcinoma and death in cirrhotic
patients [147,148]. Alcohol consumption increases reactive
oxygen species in mitochondria, which are detoxified by
MnSOD and GPX [149,150]. It is hypothesized that the
increased import of Ala-MnSOD could lead to an imbalance
between MnSOD and GPX resulting in a buildup of hydrogen
peroxide, which can then form the extremely reactive hydroxyl
radical in the presence of iron [147]. In fact, transfection with
Ala-MnSOD causes a 60% reduction in superoxide anion
levels compared to Val-MnSOD [146]. The increase in
oxidative stress due to increased activity of the Ala-isoform
of MnSOD and the subsequent increase in hydroxyl radicals
could damage mitochondria, promote both apoptotic and
necrotic cell death, and contribute to alcohol-induced liver
diseases [151].
Differences in the Val and Ala genotypes have also been
associated with nonfamilial idiopathic cardiomyopathy [152],
diabetic nephropathy in patients with type II diabetes [153], and
hereditary hemochromatosis in patients who have developeddilated or nondilated cardiomyopathy [154]. For reasons that
are not yet clear, the Val allele appears to be associated with
these disease states.
4. Diseases due to defects in the mitochondrial import and
processing machinery
4.1. Human deafness dystonia syndrome
The X-linked neurodegenerative disorder Human Deafness
Dystonia Syndrome (DDS, also known as Mohr–Tranebjaerg
syndrome) is characterized by postlingual progressive sensori-
neural deafness, dystonia, spasticity, dysphagia, mental dete-
rioration, paranoia, and cortical blindness and illustrates how a
defect in the mitochondrial import machinery can lead to human
disease [155]. DDS is caused by mutations in the IMS protein
deafness dystonia peptide 1 (DDP1/Tim8), which is homo-
logous to the fungal protein Tim8 [156,157]. In all, eight
mutations have been described in the DDP1/Tim8 gene of
patients with DDS, seven of which are either missense, deletion,
frameshift, or stop mutations [155,156,158–164]. In mamma-
lian mitochondria, DDP1/Tim8 is found in a complex with
Tim13 [165]. The most studied of the DDP1/Tim8 mutations
that causes DDS, and the one that helped elucidate the function
of DDP1/Tim8, is in a cysteine of the ‘twin Cx3C’ motif
(C66W) [166]. Tim8C66W and Tim13 were not detectable in the
cultured fibroblast cell lines from a DDS patient even though
the mRNA levels of both were detected at levels of control cells.
The mutation in yeast does not disrupt mRNA stability or
translation, and has no effect on targeting or localization to the
IMS [100], supporting the hypothesis that the absence of
Tim8C66W is due to its inability to form a stable complex in the
IMS [166].
The small Tim proteins of the IMS are characterized by a
‘twin Cx3C’ motif [167], and are proposed to be retained in the
IMS either by binding to metal cofactors [98–101], or by
forming disulfide bonds [102–106]. The C66W mutation may
cause themutated protein to incorrectly fold and lose its ability to
assemble with Tim13 because Zn2+ is required for a stably
folded wild-type DDP1/Tim8, and Tim8C66W has impaired Zn2+
binding to the zinc finger motif [100]. The folding of various
other small Tim proteins is also dependent on the coordination of
Zn2+ ions by the cysteine residues of the zinc finger motif
[98,99]. Another possibility is that the loss of the cysteine
residue may prevent Tim8C66W from interacting with Mia40,
thus preventing disulfide bond formation. Mia40 was first
identified in yeast as an IMS protein that is crucial for the
transport of the small Tim proteins across the outer membrane
and their assembly into IMS complexes [102]. Along with Erv1,
Mia40 functions to catalyze the import of proteins into the IMS
by an oxidative folding mechanism [103–105]. Although a
human Erv1 ortholog has yet to be shown to participate in the
import of IMS proteins, human Mia40 has been identified as a
component of the import pathway whose depletion affects the
steady-state levels of twin Cx3C-containing IMS proteins,
including DDP1/Tim8 [168]. Evidence to date suggests that
DDP1/Tim8 achieves a stably folded conformation in the IMS
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suggested for other proteins [102,167].
The complete absence of the DDP1/Tim8 protein was
described in a DDS patient with a missense mutation (G→C
transversion in nucleotide position 38) of the first exon [158]. The
mutation resulted in a loss of the start codon (M1I) and complete
lack of the protein, while mRNA levels were unaffected. Like the
patient with the C66W mutation, this patient exhibited typical
neurodegenerative symptoms associated with DDS, and although
Tim13 mRNA levels were unaffected, Tim13 protein levels were
significantly reduced. An intronic mutation at position −23
relative to the first nucleotide of exon 2 was identified in twomale
DDS patients and their unaffected mothers [159]. This is the only
described case of an intronic mutation being associated with DDS
and the authors suggested that the problem may have arisen from
mRNA splicing alterations.
Different hypotheses have been proposed on how a
dysfunctional DDP1/Tim8 can lead to DDS. The human
DDP1/Tim8–Tim13 complex in the IMS is directly involved
in the import of human Tim23 [165,166,169]. Based on this
finding, it has been hypothesized that the mechanism under-
lying the severity of DDS is the impaired biogenesis of the
TIM23 complex as a result of a dysfunctional Tim8. This would
lead to severe pleiotropic mitochondrial dysfunction because
the TIM23 complex is used for the import of all matrix proteins
and some IMS and inner membrane proteins. The Ca2+-
responsive aspartate/glutamate carriers, aralar1 and citrin, are
also chaperoned across the IMS by DDP1/Tim8–Tim13 to
TIM22 for insertion into the inner membrane, suggesting that
Tim8 defects could lead to decreased NADH levels due to a
decrease in the aspartate/malate NADH shuttle [169]. Finally,
the Tim8–Tim13 complex in yeast has been implicated in the
import and assembly of the outer membrane β-barrel proteins
Tom40 and porin [170,171]. If this finding is demonstrated in
humans, it could further elucidate the consequences that a
dysfunctional Tim8 can have on mitochondrial function.
4.2. Dilated cardiomyopathy with ataxia
A recent study has suggested that a defect in Pam18 (Tim14)
might be involved in dilated cardiomyopathy with ataxia
(DCMA) [172]. This novel autosomal recessive condition was
identified in the Canadian Dariusleut Hutterite population and is
characterized by early onset dilated cardiomyopathy, non-
progressive cerebral ataxia, growth failure, and in some
patients, testicular dysgenesis and 3-methylglutaconic aciduria.
Using homozygosity mapping in 11 patients with DCMA, a
novel gene was identified, DNAJC19, that shares similarity
with fungal Pam18. Pam18 is an inner membrane protein in all
eukaryotes that participates in the import of matrix proteins,
possibly by enabling mtHsp70 to interact with Tim44 in a
regulated manner [65–67]. All DCMA patients were found to
be homozygous for a G→C transversion in the AG splice
acceptor site of intron 3 of DNAJC19, while all unaffected
siblings were not [172]. The mutation resulted in a loss of exon
4 in the mRNA transcript, and it was predicted that translation
would be prematurely terminated in exon 5, leaving a proteinthat lacked the DNAJ domain. Pam18 stimulates the ATPase
activity of mtHsp70 through the J domain and disruption of the
J domain alone is sufficient to make fungal cells unviable
[66,67]. It is not yet clear if DNAJC19 is the human ortholog of
Pam18; but if it is, the DCMA phenotype might be the result of
dysfunctional import of matrix proteins through the TIM23
complex.
4.3. Atypical mitochondrial disease involving multisystem
failure
Hsp60, a mitochondrial matrix chaperone involved in the
folding and assembly of mitochondrial proteins, is the only
component of the mitochondrial folding and assembly machin-
ery whose dysfunction has been implicated in causing human
disease. Patients with an atypical mitochondria disease invol-
ving multisystem failure have been linked to a deficiency in
Hsp60 [173,174]. Analysis of their mitochondria indicated that
there was a decreased number of mitochondria per cell, and the
ones that were present had ultrastructural abnormalities, were
swollen, and were mainly localized around the nucleus [173–
175]. The enzyme activities of oxidative phosphorylation,
pyruvate metabolism, β-oxidation, and other mitochondrial
metabolic pathways were markedly decreased in cultured
fibroblasts [173,174], and the reduced levels were associated
with decreased amounts of Hsp60 [175]. In contrast, the activity
of enzymes localized in the outer membrane or in other cellular
organelles were normal [173]. The low steady state amount of
Hsp60 in the fibroblasts was caused by the decreased synthesis
of the protein and not by its enhanced degradation or ability to
oligomerize into its native 14-mer complex [176]. Although the
authors suggested that the molecular basis of the disease was a
primary defect in Hsp60 synthesis and/or processing, there has
been no evidence presented to date to support this hypothesis.
4.4. Spastic paraplegia-13
A dysfunctional Hsp60 has also been implicated in causing
spastic paraplegia-13 (SPG13), an autosomally dominant form
of pure hereditary spastic paraplegia (HSP) [177,178]. HSP
represents a clinically and genetically heterogeneous group of
neurodegenerative disorders characterized by progressive
weakness and spasticity of the lower limbs due to degeneration
of corticospinal axons. Two affected members of a family with
SPG13 were found to be heterozygous for a G→A variation at
nucleotide 292, resulting in Val→ Ile substitution at residue 72
in the mature Hsp60 protein [178]. The Hsp60V72I mutant
protein is functionally impaired when expressed in E. coli.
Taken together, the defects in Hsp60 illustrate how a disruption
in the protein folding and assembly machinery in the
mitochondrial matrix can lead to a decrease in the synthesis
and maintenance of mitochondria.
5. Dynamics of protein import
Work utilizing animal models and mammalian cell culture
has furthered our understanding of mitochondrial protein import
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human health and disease. We now recognize that mitochon-
drial protein import responds to various conditions including
oxidant stress, aging, and external stimuli.
5.1. Oxidant stress and import of DNA repair enzymes
The highly oxidative environment of mitochondria has lead
to the hypothesis that mitochondrial DNA damage contributes
to aging and disease [179], which is supported by mouse studies
that show aging may be driven by apoptosis that is caused by an
accumulation of mitochondrial DNA mutations [180]. While it
has been proposed that the targeting of DNA repair enzymes to
mitochondria could reduce oxidative stress and enhance
mitochondrial DNA repair [181], there is an age-dependent
reduction in the import of mitochondrial proteins needed for
DNA repair [182]. Although the activity of the DNA repair
enzyme 8-oxoguanine-DNA glycosylase (OGG1) is increased
in mitochondria from older mice livers and pre-senescent
primary human fibroblasts, a large fraction of the enzyme is
stuck in the outer membrane in the precursor form where it
would be unable to functionally interact with DNA [182].
Mitochondrial uracil-DNA glycosylase (UDG), another DNA
repair enzyme, is also trapped in the outer membrane of
hepatocyte mitochondria. Neither protein is found as an import
intermediate in hepatocytes from young mice or in replicating
fibroblasts, implicating that the impaired import of these
enzymes is a result of aging.
It is not currently known why these proteins become stuck in
the import machinery. Oxidative stress inhibits the import and
processing of other matrix proteins in vitro and in vivo [183].
Thus, import may be affected because of the age-associated
mitochondrial dysfunctions resulting from cumulative oxidative
damage that decrease the mitochondrial inner membrane ΔΨ
and membrane fluidity, and alter expression of genes involved
in mitochondrial bioenergetics [184]. Aging has been directly
associated with an increase in mitochondrial inner membrane
proton permeability in mitochondria from hepatocytes, lym-
phocytes, and cardiomyocytes [185–188]. Since experimentally
dissipating the ΔΨ causes precursor proteins to remain in the
TOM complex [189,190], it is possible that the age-related
decrease in ΔΨ causes these DNA repair enzymes to become
stuck in mid-translocation. It is unclear whether this phenom-
enon would be specific for OGG1 and UDG, or would apply to
all matrix proteins. However, as discussed above with the
import of MnSOD, small variations in MTSs can have an affect
on the complete translocation of precursor proteins into the
matrix [145]. It is likely that different proteins will have varying
degrees of import problems as a result of a diminished ΔΨ.
5.2. Thyroid hormone treatment
Mitochondria derived from cardiac muscle of animals treated
with thyroid hormone (T3) have a 40–60% higher import rate of
matrix proteins, and an associated increase in components of the
import machinery (Tom20, mtHsp70, and Hsp60) [191]. T3
treatment also causes an increase in cardiac Tim23 and Tim44mRNA levels by 50%, and 55%, respectively [192]. The
increase in mtHsp70 is due to both an increase in mRNA
production and a higher import rate of the precursor mtHsp70
protein [193]. Although protein degradation and cytosolic
factors are likely important in maintaining steady-state levels of
mitochondrial proteins, they have little effect on mediating T3-
induced changes [191].
5.3. Chronic skeletal muscle stimulation
Chronic stimulation of skeletal muscle causes changes in
mitochondrial protein import. Isolated mitochondria from
muscles that have been chronically stimulated electrically, or
by endurance training, have an increased import rate of matrix
proteins as well as increases in the expression of components
involved in import (Tom20, mtHsp70, Hsp60, and Hsp10)
[194–196]. Chronic muscle contraction stimulates the synthesis
and degradation of proteins that are directly involved in
contraction and energy production, as well as promoting the
biogenesis of new mitochondria [197,198]. The upregulation of
these protein import components may be to ensure the proper
import of proteins during organelle synthesis [194]. Protein
import and the ATP producing capabilities of mitochondria are
directly related [199], and exercise causes an increase in State
III and the coupling ratio in skeletal muscle mitochondria [200].
It is possible that the change in import during chronic muscle
stimulation is due to an increase in the respiratory state of the
mitochondria. This is supported by the finding that chronic
contractile activity does not affect the import of outer membrane
proteins [195], which do not use the ΔΨ for import [201–203].
6. Conclusions and perspectives
Proper mitochondrial functioning is dependent on the
interactions of proteins from both the nuclear and mitochondrial
genomes. As described above, the targeting, import, and
processing of nuclearly-encoded mitochondrial proteins have
a direct effect on human health and disease. However, there are
undoubtedly more disease states that are caused by errors in
mitochondrial protein import. For example, an error in the
proteolytic maturation of a protein by either MPP or MIP could
lead to a non-functional protein. Our understanding of import as
a regulated series of events is also continuing to expand. It was
recently shown that Mge1 acts as a thermosensor for the
mtHsp70 system, as heat shock induces the conversion of Mge1
from the active dimeric form to an inactive monomeric form
[204]. The inactive form is unable to regulate the mtHsp70
ATPase and chaperone cycle. This conversion between active
and inactive forms would allow for a reversible inhibition of the
import of newly synthesized proteins so as to decrease the
amount of aggregation-prone proteins in the matrix during
stress.
Although it is well established that mitochondrial proteins
can be imported post-translationally, evidence suggests that
some proteins may be targeted and imported co-translationally
[23,205]. This alternate delivery system, if validated, would
offer a new set of mechanisms that may be important in human
Table 3
Components in protein import into fungal and human mitochondria
Fungal Human
Cytosolic chaperones Hsp70 Hsc70 [219]
Ydj1p DjA1 [28], DjA2 [29]
AIP [27]
Hsp90 [30]
TOM Tom40 Tom40 [50,220] a
Tom22 Tom22 [39,221]
Tom70 Tom70 [222] a
Tom20 Tom20 [26,223]
Tom7 Tom7 [37] a
Tom6
Tom5












TIM23 Tim23 Tim23 [225] a
Tim17 Tim17a [225,226] a,
Tim17b [225] a
Tim50 Tim50 [227] a
Tim21
PAM Tim44 Tim44 [225] a
mtHsp70 mtHsp70 [228] a
Mge1 mtGrpE [229] a
Pam18
Pam16
OXA Oxa1 Oxa1 [114]
IMP Imp1 Imp1 [230] b
Imp2 Imp2 [231] b
Som1
Matrix Mas1 β-MPP [232] b




mtHsp70 mtHsp70 [228] a
Mdj1 Tid [237,238]
Mge1 mtGrpE [229] a
a The human protein has been identified and localizes to mitochondria;
however, any role in protein import and processing is only inferred from its
fungal and mammalian orthologs.
b Only the human DNA sequence has been identified.
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nascent polypeptide-associated complex (NAC) in yeast inter-
acts with nascent precursor proteins, promotes ribosome
docking to the mitochondrial surface, and its disruption leads
to defects in protein targeting to mitochondria [206–208]. Two
important mechanisms must be present for co-translational
targeting to occur, namely, translational inhibition of mitochon-
drial proteins, and the specific targeting of ribosomes translating
mitochondrial proteins. Translational inhibition is important to
allow for targeting to occur before the protein is fully translated.
This event has recently been shown to occur in vivo in slime
mold for some mitochondrial proteins [209]. While the
mechanism for this translational inhibition is unknown, it is
probable that cytosolic factors are involved in a manner similar
to what the signal recognition particle does in the co-
translational import of proteins to the endoplasmic reticulum
[210]. Targeting ribosomes to mitochondria may also involve
mechanisms susceptible to damage. Mammalian mitochondria
bind ribosomes in a receptor-like manner that uses GTP
hydrolysis to differentiate between ribosomes carrying mito-
chondrial proteins to ones that do not [211,212]. While evidence
suggests that mitochondria contain a specific ribosome receptor
and that there are GTP-binding protein(s) that participate in the
recognition and binding of ribosomes carrying mitochondrial
proteins, neither has been identified. Problems with NAC, or
any of the hypothesized proteins that may participate in the
translational pausing and ribosomal delivery of proteins to
mitochondria, are some of the possible places that errors in co-
translational targeting could lead to disease. This may be highly
relevant, for example, during periods of high oxidant stress,
such as ischemia–reperfusion injury (e.g., heart attacks,
strokes), where multiple intracellular processes have been
disrupted. In this situation, mitochondria may no longer be able
to meet the metabolic demands of the cell, and cell death ensues.
As more evidence for co-translational import is found, and more
of the mechanisms are worked out, it is very possible that these
events may also be found to contribute to overall mitochondrial
function, and the subsequent health of humans.
Of the hundreds of mitochondrial proteins in mammals,
thirteen are encoded by mitochondrial DNA and include
components of complexes I, III, IV, and V of the oxidative
phosphorylation system. Mitochondrially-encoded inner
membrane proteins are exported via Oxa1-dependent and
-independent pathways [113,115], which offer yet another set
of targeting and insertion mechanisms where defects could lead
to human disease. Recent evidence suggests that Wolf–Hirsch-
horn syndrome (WHS) may be caused, in part, by the lack of a
nuclearly-encoded mitochondrial protein that is involved in the
export of mitochondrially-encoded inner membrane proteins.
WHS is a multigenic disease resulting from variably-sized
deletions in the subtelomeric region of chromosome 4 that lead
to a complex and variable phenotype of severe neurological and
neuromuscular abnormalities [213]. In most cases of WHS there
is a deletion of the Letm1 gene [214], which is an ortholog to the
yeast inner membrane proteins Mdm38 and Ylh47 [215–217].
Mdm38 is involved in one of the Oxa1-independent export
pathways in yeast, where it interacts with newly synthesizedproteins and forms stable complexes with mitochondrial
ribosomes [218]. Mdm38 is required for the efficient export of
cytochrome b and Atp6 and to a lesser extent Cox1 and -2; and
Δmdm38 yeast cells have reduced Complex III and IV levels, an
accumulation of unassembled Atp6 of Complex V, and a
significant reduction in the ΔΨ [218]. Although the molecular
function of Letm1 is still unknown, its functional similarity to
Mdm38 is demonstrated in that it can partially rescue growth
defects in Δmdm38 yeast [215]. The role of Mdm38 in the
biogenesis of the respiratory chain in yeast might explain how
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associated with mitochondrial diseases.
While the import of nuclearly-encoded mitochondrial
proteins has been highly conserved throughout eukaryotic
evolution, and it is useful to make inferences on mammalian
import based on import in fungi, there are differences in both the
machinery and the mechanisms. For example, Tom40 is inserted
into the outer membrane via Sam50 in both yeast and humans,
but the import intermediates that are formed differ in size and
susceptibility to externally added protease [50]. Although there
have been great strides in identifying and characterizing the
human counterparts of the mitochondria import machinery
(Table 3), much is still unknown. The precise roles of some of
the identified human import components have not been
completely elucidated and only the genes for others have been
identified. Based on the known components in fungi, it is
probable that there are many more human components that have
yet to be identified. To further our understanding of how errors
in the import process contribute to a disease state, the following
should be addressed: (1) all of the components of the human
import machinery need to be determined, (2) the human
mitochondrial import apparatus needs to be fully characterized,
and (3) those components of the import machinery that are
likely to be compromised by inherited mutations, or may be
damaged by acquired defects such as oxidant stress, need to be
determined. Only when we have a complete understanding of
the targeting and import process in humans, and how it changes
to accommodate the specific needs and conditions of a cell, can
attempts then be made to manipulate the system to achieve
desirable outcomes.
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